Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

GTx, Inc (GTXI): Play Smart, Stay Neutral

|Includes:GTx, Inc. (GTXI)

GTx, Inc (NASDAQ:GTXI)

Whether acopodene will be approved this Friday, October 30 is hard to determine with any certainty.

November $10 call options are overpriced. 

Odds of approval are favorable at 60%.

If I had a extra capital laying around to gamble on GTXI, then I might build a neutral position, i.e. in the money or at the money straddle or strangle.

Disclosure: No position.

Stocks: GTXI